MedApp: Start-up offers solutions for imaging diagnostics and digital medicine

Information on accessibility

00:00:01 #NeueGründerzeit "The German health market is one of the most important ones for us", Krzysztof Mędrala; MedApp S.A.

00:00:03 Krzysztof Mędrala; MedApp S.A., CEO

00:00:14 MedApp – Empowering people for better health 00:03:10 Start.up! Germany Tour – Innovative startups from all over the world introduce themselves and learn about the advantages of NRW as a location.

English transcript

 #NeueGründerzeit "The German health market is one of the most important ones for us", Krzysztof Mędrala; MedApp S.A.

My name is Krzysztof Mędrala. I'm the CEO of MedApp software company in Krakow. MedApp is concentrating on three main pillars, three main competencies. This is artificial intelligence, big data analysis and 3D imaging. Based on these three competencies, we are offering medical software for patients, clinics, and hospitals.

Currently we have two main products which are certified as a C2B class software. One is "CarnaLife Holo". This is a 3D imaging solution which helps the doctors for preparing and during a treatment in cardiology, oncology or orthopedics. It means that during a treatment or before the treatment, the doctors have much more information, can be much better prepared for a treatment or surgery. And finally, based on our experience, we are able to cut the time of the treatment by almost 30 to 35%.

The second application, "CarnaLife System", is mainly based on artificial intelligence and big data analysis. This is a software which is collecting the data from external resources like thermometers, blood pressure monitors, scales with body composition, CGMs. And our algorithms analyze this information and prepare it for a doctor. It means that it's a fully remote diagnosis clinic which allows for services, remote diagnosis and monitoring for a patient. We put attention on empowering people for better health. That's very important for us that we have not only developed the IT software solution, we believe that we are really helping people for better health.

That's the mission, that's the power which allows us to grow and drive this business and that's the DNA of our whole organization – all people believe in it. That's really, really a part of our life. Our company was founded in 2010. Basically, at the beginning the company offered games, but in 2016 we changed the business line. We moved to service and software dedicated for medical clients.

And since 2016 we develop, we offer our current product which is already certified since 2017. Now we are preparing for FDA certification, because we want to expand outside of Poland. We plan to expand to German DACH region since 2020. In 2021 we got the invitation to take part in a German start-up tour that privileged us to present our solution to German colleagues, to the colleagues from other countries.

Based on the potential big market and the expectation from the health services, we think that the German market can be one of the most important for us. We know how active our local government in Westfalia region is. We know that they have the healthcare hub and we decided to register the company. And now we are in the process. We believe that at the end of this quarter we'll be able to start operational activity in Germany, from Düsseldorf.

And further, we believe that from Düsseldorf, we will be able to service Switzerland and Austria as the next markets in the DACH region. We, as a company, are looking for partners and clients. We are searching for potential cooperation. It means we know that we currently offer a good service, a good product. But we know that we have so many opportunities to cooperate with some other partners, who for example have sales networks, the access to some data which we can use for improving our algorithm and we believe that on the German market we can get it. Based on the fact, that we are listed on the Frankfurt Stock Exchange, the German patients, German clients, German investors will know much more about the MedApp day by day and they will support us for further growing.

 We believe that next year will be profitable for our German company "MedApp Germany" and we will be able to offer some additional functionality which will be needed for the German market, maybe also dedicated for the DACH region. But I believe with time we as MedApp Poland or our subsidiary or our distributor will want to participate in this and will offer this product which the German MedApp from Düsseldorf offers.